General Information of Drug (ID:
DR0624) |
Drug Name |
Eslicarbazepine acetate
|
Prodrug Info |
Eslicarbazepine acetate is the prodrug of Eslicarbazepine
|
Synonyms |
Eslicarbazepine (acetate); Eslicarbazepine acetate; Eslicarbazepine acetate (USAN); Eslicarbazepine acetate [USAN]; Exalief; SEP-0002093; Sep 0002093; Stedesa; UNII-BEA68ZVB2K; Zebinix; [(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate; Exelief; (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; (S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate; 236395-14-5; Aptiom; BEA68ZVB2K; BIA 2-093; BIA 2093; BIA-2-093; CHEBI:87016; CHEMBL87992
|
Indication |
Epilepsy
[ICD11: 8A60]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
296.32 |
Topological Polar Surface Area |
72.6 |
Heavy Atom Count |
22 |
Rotatable Bond Count |
2 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
3 |
Cross-matching ID |
- PubChem CID
- 179344
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D04QZD
- Formula
- C17H16N2O3
- Canonical SMILES
- CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N
- InChI
- 1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1
- InChIKey
- QIALRBLEEWJACW-INIZCTEOSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.